Q&A with Renalytix Executive Chairman, Julian Baines
10 days ago
Renalytix #RENX, specialises in AI-powered diagnostics for kidney disease. Executive Chairman Julian Baines, in an interview with Vox Markets, highlighted the company's FDA-approved test, KidneyIntelX, which predicts end-stage renal disease risk in diabetic patients, improving outcomes and reducing healthcare costs. The company is now commercially focused, showing steady revenue growth and aiming for break-even by 2025.